Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples

Journal of Virological Methods

Volumn 184, Issue 1-2, 2012, Pages 46-54

  Nourse, Jamie P ^a   Crooks, Pauline ^a   Keane, Colm ^a,b   Nguyen Van, Do ^a   Mujaj, Sally ^a   Ross, Nathan ^a   Jones, Kimberley ^a   Vari, Frank ^a   Han, Erica ^a   Trappe, Ralf ^c   Fink, Susanne ^a,d   Gandhi, Maher K ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Epstein Barr virus; Formalin fixed paraffin embedded; MicroRNA; Post transplant lymphoproliferative disorders; Real time RT PCR

Indexed keywords

FORMALDEHYDE; MICRORNA; PARAFFIN; PROTEIN EBER2; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CALIBRATOR; CANCER INFILTRATION; CHILD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EMBEDDING; EPSTEIN BARR VIRUS; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA CELL; MALE; NONHUMAN; PARAFFIN EMBEDDED FORMALIN FIXED TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE FIXATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LOAD;

ADULT; AGED; FEMALE; FORMALDEHYDE; GENE EXPRESSION PROFILING; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL; MALE; MICRORNAS; MIDDLE AGED; PARAFFIN EMBEDDING; PATHOLOGY, MOLECULAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; TISSUE FIXATION;

HUMAN HERPESVIRUS 4;

EID: 84863853922     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.05.005     Document Type: Article

References (33)

1. Amoroso R., Fitzsimmons L., Thomas W.A., Kelly G.L., Rowe M., Bell A.I. Quantitative studies of Epstein-Barr virus-encoded miRNAs provide novel insights into their regulation. Journal of Virology 2010, 85:996-1010.
2. Cai X., Schäfer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., Raab-Traub N., Cullen B.R. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathogens 2006, 2:e23.
3. Cohen J.I., Kimura H., Nakamura S., Ko Y.-H., Jaffe E.S. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Annals of Oncology 2009, 20:1472-1482.
4. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., Thorley-Lawson D.A. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. Journal of Virology 2009, 83:2357-2367.
5. Edwards R.H., Marquitz A.R., Raab-Traub N. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. Journal of Virology 2008, 82:9094-9106.
6. Feederle R., Haar J., Bernhardt K., Linnstaedt S.D., Bannert H., Lips H., Cullen B.R., Delecluse H.-J. The members of a viral miRNA cluster co-operate to transform B lymphocytes. Journal of Virology 2011, 85:9801-9810.
7. Gandhi M.K., Lambley E., Burrows J., Dua U., Elliott S., Shaw P.J., Prince H.M., Wolf M., Clarke K., Underhill C., Mills T., Mollee P., Gill D., Marlton P., Seymour J.F., Khanna R. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clinical Cancer Research 2006, 12:460-464.
8. Greifenegger N., Jäger M., Kunz-Schughart L.A., Wolf H., Schwarzmann F. Epstein-Barr virus small RNA (EBER) genes: differential regulation during lytic viral replication. Journal of Virology 1998, 72:9323-9328.
9. Grundhoff A., Sullivan C.S., Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006, 12:733-750.
10. Imig J., Motsch N., Zhu J.Y., Barth S., Okoniewski M., Reineke T., Tinguely M., Faggioni A., Trivedi P., Meister G., Renner C., Grässer F.A. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Research 2010, 39:1880-1893.
11. Jun S.M., Hong Y.S., Seo J.S., Ko Y.H., Yang C.W., Lee S.K. Viral microRNA profile in Epstein-Barr virus-associated peripheral T cell lymphoma. British Journal of Haematology 2008, 142:320-323.
12. Kim D.N., Chae H.-S., Oh S.T., Kang J.-H., Park C.H., Park W.S., Takada K., Lee J.M., Lee W.-K., Lee S.K. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. Journal of Virology 2007, 81:1033-1036.
13. Küppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nature Reviews Immunology 2003, 3:801-812.
14. Leight E.R., Sugden B. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Molecular and Cellular Biology 2001, 21:4149-4161.
15. Masuda N., Ohnishi T., Kawamoto S., Monden M., Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Research 1999, 27:4436-4443.
16. Nakamura, Jaffe, S., Swerdlow, E., SH, 2008. EBV Positive Diffuse Large B-cell Lymphoma of the Elderly. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 243-244.
17. Nguyen-Van D., Keane C., Han E., Jones K., Nourse J., Vari F., Ross N., Crooks P., Ramuz O., Green M., Griffith L., Tappe R., Grigg A., Mollee P., Gandhi M. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly expresses EBNA3A with conserved CD8+ T-cell epitopes. American Journal of Blood Research 2011, 1:146-159.
18. Nourse J.P., Jones K., Gandhi M.K. Epstein-barr virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy. American Journal of Transplantation 2011, 11:888-895.
19. Pfeffer S., Zavolan M., Grässer F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
20. Pratt Z.L., Kuzembayeva M., Sengupta S., Sugden B. The microRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell-lines. Virology 2009, 386:387-397.
21. Qiu J., Cosmopoulos K., Pegtel M., Hopmans E., Murray P., Middeldorp J., Shapiro M., Thorley-Lawson D.A. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathogens 2011, 7:e1002193.
22. Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986, 47:883-889.
23. Reichenstein I., Aizenberg N., Goshen M., Bentwich Z., Avni Y.S. A novel qPCR assay for viral encoded microRNAs. Journal of Virological Methods 2010, 163:323-328.
24. Seto E., Moosmann A., Grömminger S., Walz N., Grundhoff A., Hammerschmidt W. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathogens 2010, 6:e1001063.
25. Shannon-Lowe C., Adland E., Bell A.I., Delecluse H.-J., Rickinson A.B., Rowe M. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. Journal of Virology 2009, 83:7749-7760.
26. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J., Vardiman J.W. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, IARC, Lyon. fourth ed.
27. Thorley-Lawson D.A., Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. New England Journal of Medicine 2004, 350:1328-1337.
28. Weng L., Wu X., Gao H., Mu B., Li X., Wang J.-H., Guo C., Jin J.M., Chen Z., Covarrubias M., Yuan Y.-C., Weiss L.M., Wu H. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. Journal of Pathology 2010, 222:41-51.
29. Xia T., O'Hara A., Araujo I., Barreto J., Carvalho E., Sapucaia J.B., Ramos J.C., Luz E., Pedroso C., Manrique M., Toomey N.L., Brites C., Dittmer D.P., Harrington W.J. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Research 2008, 68:1436-1442.
30. Xing L., Kieff E. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. Journal of Virology 2007, 81:9967-9975.
31. Yao Y., Minter H.A., Chen X., Reynolds G.M., Bromley M., Arrand J.R. Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. International Journal of Cancer 2000, 88:949-955.
32. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years on. Nature Reviews Cancer 2004, 4:757-768.
33. Zhu J.Y., Pfuhl T., Motsch N., Barth S., Nicholls J., Grässer F., Meister G. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. Journal of Virology 2009, 83:3333-3341.